It is widely recognized that in males, decreased testosterone level increases the risk of AD (Pike, 2017), while in females, decreased plasma testosterone correlates with significantly increased cerebrospinal fluid levels of phosphorylated tau (Sundermann et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.